Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 301-037-8 | CAS number: 93980-59-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 10 Dec 2020 - 09 Mar 2021
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 021
- Report date:
- 2021
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test using the Hprt and xprt genes)
- Version / remarks:
- adopted in 2016
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- adopted in 2008
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Ogyéi National Institute of Pharmacy and Nutrition, Budapest, Hungary
- Type of assay:
- in vitro mammalian cell gene mutation test using the Hprt and xprt genes
Test material
- Reference substance name:
- Sorbitan, tridocosanoate
- EC Number:
- 301-037-8
- EC Name:
- Sorbitan, tridocosanoate
- Cas Number:
- 93980-59-7
- Molecular formula:
- C72H138O8
- IUPAC Name:
- Sorbitan tridocosanoate
- Test material form:
- solid: particulate/powder
Constituent 1
Method
- Target gene:
- HGPRT
Species / strain
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Remarks:
- Subline K1
- Details on mammalian cell type (if applicable):
- CELLS USED
- Type and source of cells: American Type Culture Collection (ATCC, Manassas, Virginia, United States)
- Absence of Mycoplasma contamination: yes
- Methods for maintenance in cell culture: Cells were cultivated in F12-10 culture medium (see below) and incubated at 37 ± 0.5 °C in a humidified atmosphere at 5 ± 0.3° CO2 in air.
- Periodically ‘cleansed’ of spontaneous mutants: yes. Prior to use in the test, the culture was cleansed of pre-existing mutant cells by culturing in HAT medium.
MEDIA USED
- F12-1 medium: Treatment medium for 5 h treatment -S9 mix
Ham's F12 medium supplemented with 1% heat inactivated foetal bovine serum (FBS), 0.001 mL/mL L-glutamine and 0.01 mL/mL antibiotic/antimycotic solution (consisting of 10000 NE/mL penicillin, 10 mg/mL streptomycin and 25 µg/mL amphotericin-B)
- F12-5 medium: Treatment medium for 5 h treatment +S9 mix
Ham's F12 medium supplemented with 5% heat inactivated FBS, 0.001 mL/mL L-glutamine and 0.01 mL/mL antibiotic/antimycotic solution (consisting of 10000 NE/mL penicillin, 10 mg/mL streptomycin and 25 µg/mL amphotericin-B)
- F12-10 medium: General culture medium
Ham's F12 medium supplemented with 10% heat inactivated FBS, 0.001 mL/mL L-glutamine and 0.01 mL/mL antibiotic/antimycotic solution (consisting of 10000 NE/mL penicillin, 10 mg/mL streptomycin and 25 µg/mL amphotericin-B)
- F12-SEL medium: Culture medium for selection
Hypoxanthine-free Ham's F12 medium supplemented with 10% heat inactivated FBS, 0.001 mL/mL L-glutamine and 0.01 mL/mL antibiotic/antimycotic solution (consisting of 10000 NE/mL penicillin, 10 mg/mL streptomycin and 25 µg/mL amphotericin-B)
- Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system: Cofactor supplemented post mitochondrial fraction (S9 mix).
- source of S9: in house of the testing facility
- method of preparation of S9 mix: S9 mix was prepared from the livers of male Wistar rats (502 - 672 g) that were 5 months old. The animals were induced with phenobarbital and β-naphthoflavone at 80 mg/kg bw/day by oral gavage for three consecutive days. Liver homogenates were prepared 4 days after induction.
S9 mix was composed of 20 mM HEPES, 330 mM KCl, 50 mM MgCl2, 40 mM NADP, 50 mM D-glucose-6-phosphate and S9 fraction (30% in S9 mix).
- concentration or volume of S9 mix in the final culture medium: 10%
- quality controls of S9 (e.g., enzymatic activity, sterility, metabolic capability): The biological activity of the S9 mix was demonstrated in an Ames test using the reference mutagens 2-aminoanthracene and benzo[a]pyrene. - Test concentrations with justification for top dose:
- Preliminary cytotoxicity test:
With and without metabolic activation: 3.906, 7.813, 15.625, 31.25, 62.5, 125, 250, 500, 1000 and 2000 µg/mL (5 h)
Experiment 1:
With and without metabolic activation: 2.74, 8.23, 24.69, 74.07, 222.22, 666.67 and 2000 µg/mL (5 h)
Experiment 2:
With metabolic activation: 2.74, 8.23, 24.69, 74.07, 222.22, 666.67 and 2000 µg/mL (5 h)
Without metabolic activation: 2.74, 8.23, 24.69, 74.07, 222.22, 666.67 and 2000 µg/mL (24 h)
Justification for top concentration: Concentrations were selected based on the results of a preliminary cytotoxicity test. There was no cytotoxicity observed up to and including the maximum dose of 2000 µg/mL. - Vehicle / solvent:
- - Vehicle/solvent used: Dimethyl sulfoxide (DMSO), 1% in the final culture medium
- Justification for choice of solvent/vehicle: In a trial experiment, the test item turned out to be insoluble in water. Formulations in DMSO and in 1% aqueous methyl cellulose solution gave visibly homogeneous suspensions. Therefore, DMSO was selected as vehicle of the study.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- 1% DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: duplicate
- Number of independent experiments: 2
METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding: 2 x 10E6 (in dishes of 100 mm diameter)
- Test substance added in medium (F12-1 for 5 h exposure ± S9 mix, F12-5 for 24 h exposure –S9 mix).
TREATMENT AND HARVEST SCHEDULE:
- Exposure duration/duration of treatment: 5 h with and without S9 mix (Experiments 1 and 2) and 24 h without S9 mix (Experiment 2)
- Expression time: At the end of the treatment period, the cultures were re-plated and incubated for a 7 days expression period. The cells were sub-cultured and maintained at 2 x 10E5 cells/dish twice.
- Selection time: After the expression period, 4 x 10E5 cells were plated in 100 mm dishes (5 per sample) for determination of mutant frequency and incubated for 7 days.
- Fixation time (start of exposure up to fixation or harvest of cells): 14 days
SELECTION:
- selection agent: 20 µg/mL 6-thioguanine (6-TG) was added to the medium for the 7-days incubation period of mutant selection.
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: Relative survival (RS) and cloning efficiency
METHODS FOR MEASUREMENTS OF GENOTOXICIY:
The mutant frequency was calculated by dividing the total number of mutant colonies by the number of cells selected (2x10E6 cells: 5 plates at 4x10E5 cells/plate), corrected for the cloning efficiency of cells prior to mutant selection (viability), and were expressed as 6-TG resistant mutants per 10E6 clonable cells. - Evaluation criteria:
- The test item was considered to be mutagenic in this assay if the following criteria were met:
1. The assay is valid.
2. The mutant frequency at one or more doses is significantly greater than that of the relevant negative (vehicle) control (p<0.05).
3. Increase of the mutant frequency is reproducible.
4. There is a dose-response relationship.
5. The historical control range is considered when deciding if the result is positive.
Results which only partially met the criteria were dealt with on a case-by-case basis (historical control data of untreated control samples was taken into consideration if necessary). According to the relevant OECD 476 guideline, the biological relevance of the results was considered first, statistical significance was not the only determination factor for a positive response. - Statistics:
- The mutation frequencies were statistically analysed. Statistical evaluation of data was performed with the SPSS PC+4.0 statistical program package (SPSS Hungary Ltd., Budapest, Hungary). The heterogeneity of variance between groups was checked by Bartlett`s test. Where no significant heterogeneity was detected, a one-way analysis of variance (ANOVA) was carried out. If the obtained result was significant, Duncan’s Multiple Range test was used to assess the significance of inter-group differences. Where significant heterogeneity was found, the normal distribution of data was examined by Kolmogorow-Smirnow test. In the case of not normal distribution, the nonparametric method of Kruskal-Wallis One-Way analysis of variance was applied. If a positive result was detected, the inter-group comparisons were performed using MannWhitney U-test. Data also were checked for a trend in mutation frequency with treatment dose using Microsoft Excel 2010 software (R-squared values were calculated for the log concentration versus the mutation frequency). In the statistical analysis, negative trends were not considered significant.
Results and discussion
Test results
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- In Exp. 2 (5 h exposure +S9 mix) a statistically significant increase in mutant frequency was observed at 24.69 µg/mL. The effect was not dose dependent and within historical control data and therefore considered not relevant.
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Data on pH: There were no significant changes in pH after treatment.
- Data on osmolality: There were no significant changes in osmolality after treatment.
- Precipitation and time of the determination: Precipitation was observed in both experiments at 24.69 – 2000 µg/mL at the end of treatment in the presence and absence of metabolic activation. The precipitate did not interfere with the reading of the results.
RANGE-FINDING/SCREENING STUDIES:
A preliminary cytotoxicity test was performed using test item concentrations in the range of 3.906 – 2000 µg/mL in the presence and absence of metabolic activation. The cells were exposed for 5 h ±S9 mix and for 24 h –S9 mix. There was no cytotoxicity observed at any concentration, neither with nor without S9 mix. Precipitation was observed at 15.625 – 2000 µg/mL after 5 h exposure with S9 mix and at 31.25 – 2000 µg/mL after 5 or 24 h without S9 mix.
STUDY RESULTS
Cytotoxicity:
There was no cytotoxicity observed in any experiment up to the highest dose tested, neither in presence nor absence of metabolic activation.
Mutagenicity:
In the first experiment, no statistically significant increase in the mutant frequency was observed at any dose level, neither with nor without S9 mix. In the second experiment after 5 h exposure with S9 mix, a statistically significant increase in mutant frequency was observed at 24.69 µg/mL. The finding was not dose-related and fell within the range of the laboratory’s historical control data and was therefore not considered relevant. The test item was concluded to be negative for mutagenicity in mammalian cells in vitro. For details on experimental results, please refer to Tables 1 and 2 under “Any other information on results incl. tables”.
- Concurrent vehicle, negative and positive control data were in accordance with the general historical control data generated in the testing facility for all assays. The positive controls DMBA in the presence of S9 mix and EMS in the absence of S9 mix induced statistically significant increases in the mutant frequency over those of controls, thus confirming the functionality of the S9 mix and demonstrating the sensitivity of the test.
HISTORICAL CONTROL DATA: Please refer to Table 3 under “Any other information on results incl. tables”.
Any other information on results incl. tables
Table 1: Results of Experiment 1
S9 | Treatment | Concentration | Survival | Viability | Mutagenicity | ||||
Total no. of colonies | Cloning efficiency (CE) | Relative survival (%) | Total no. of colonies | Cloning efficiency (CE) | Total no. of colonies | Mutant frequency | |||
+ | 5 | 2000 µg/mL (P) | 1179 | 0.983 | 89 | 1123 | 0.936 | 24 | 6.4 |
666.67 µg/mL (P) | 1177 | 0.981 | 89 | 978 | 0.815 | 19 | 5.8 | ||
222.22 µg/mL (P) | 1202 | 1.002 | 91 | 1142 | 0.952 | 18 | 4.7 | ||
74.07 µg/mL (P) | 1089 | 0.908 | 83 | 1117 | 0.931 | 25 | 6.7 | ||
24.69 µg/mL (P) | 1374 | 1.145 | 104 | 1162 | 0.968 | 26 | 6.7 | ||
8.23 µg/mL | 1260 | 1.050 | 96 | 1157 | 0.964 | 22 | 5.7 | ||
2.74 µg/mL | 1219 | 1.016 | 92 | 1121 | 0.934 | 21 | 5.6 | ||
Negative control | 1319 | 1.099 | 100 | 1141 | 0.951 | 22 | 5.8 | ||
Untreated control | 1196 | 0.997 | 91 | 1092 | 0.910 | 23 | 6.3 | ||
Positive control (DMBA) | 59 | 0.049 | 4 | 1188 | 0.990 | 2244 | 566.3** | ||
- | 5 | 2000 µg/mL (P) | 1152 | 0.960 | 107 | 1126 | 0.938 | 21 | 5.7 |
666.67 µg/mL (P) | 1172 | 0.977 | 109 | 1181 | 0.984 | 32 | 8 | ||
222.22 µg/mL (P) | 1321 | 1.101 | 123 | 1077 | 0.898 | 21 | 5.8 | ||
74.07 µg/mL (P) | 1284 | 1.070 | 120 | 1047 | 0.873 | 19 | 5.4 | ||
24.69 µg/mL (P) | 1306 | 1.088 | 122 | 1248 | 1.040 | 22 | 5.4 | ||
8.23 µg/mL | 1203 | 1.003 | 112 | 1122 | 0.935 | 26 | 7 | ||
2.74 µg/mL | 1189 | 0.991 | 111 | 1020 | 0.850 | 25 | 7.3 | ||
Negative control | 1074 | 0.895 | 100 | 1185 | 0.988 | 26 | 6.6 | ||
Untreated control | 1234 | 1.028 | 115 | 1180 | 0.983 | 20 | 5.1 | ||
Positive control (EMS) | 899 | 0.749 | 84 | 970 | 0.808 | 1089 | 337.0** | ||
DMBA = 7,12-Dimethylbenz[a]anthracene, 15 µg/mL; EMS = Ethyl methanesulfonate, 0.4 µL/mL; (P): precipitation observed at the end of treatment |
Table 2: Results of Experiment 2
S9 | Treatment | Concentration | Survival | Viability | Mutagenicity | ||||
Total no. of colonies | Cloning efficiency (CE) | Relative survival (%) | Total no. of colonies | Cloning efficiency (CE) | Total no. of colonies | Mutant frequency | |||
+ | 5 | 2000 µg/mL (P) | 1475 | 1.229 | 122 | 1127 | 0.939 | 22 | 5.9 |
666.67 µg/mL (P) | 1235 | 1.029 | 102 | 1051 | 0.876 | 23 | 6.6 | ||
222.22 µg/mL (P) | 1290 | 1.075 | 106 | 1060 | 0.883 | 32 | 9.1 | ||
74.07 µg/mL (P) | 1232 | 1.027 | 102 | 1113 | 0.928 | 21 | 5.7 | ||
24.69 µg/mL (P) | 1264 | 1.053 | 104 | 1048 | 0.873 | 35 | 10.1* | ||
8.23 µg/mL | 1152 | 0.960 | 95 | 1003 | 0.836 | 37 | 11 | ||
2.74 µg/mL | 1194 | 0.995 | 98 | 1090 | 0.908 | 42 | 11.4 | ||
Negative control | 1213 | 1.011 | 100 | 1125 | 0.938 | 29 | 7.7 | ||
Untreated control | 1179 | 0.983 | 97 | 1077 | 0.898 | 34 | 9.5 | ||
Positive control (DMBA) | 95 | 0.079 | 8 | 1115 | 0.929 | 1687 | 453.3** | ||
- | 24 | 2000 µg/mL (P) | 1267 | 1.056 | 97 | 1179 | 0.983 | 24 | 6.1 |
666.67 µg/mL (P) | 1361 | 1.134 | 104 | 1042 | 0.868 | 20 | 5.7 | ||
222.22 µg/mL (P) | 1406 | 1.172 | 108 | 1144 | 0.953 | 23 | 6 | ||
74.07 µg/mL (P) | 1332 | 1.110 | 102 | 1104 | 0.920 | 22 | 6 | ||
24.69 µg/mL (P) | 1256 | 1.047 | 96 | 1129 | 0.941 | 38 | 10 | ||
8.23 µg/mL | 1344 | 1.120 | 103 | 1130 | 0.942 | 21 | 5.6 | ||
2.74 µg/mL | 1258 | 1.048 | 96 | 1016 | 0.847 | 28 | 8.3 | ||
Negative control | 1304 | 1.087 | 100 | 1137 | 0.948 | 30 | 8 | ||
Untreated control | 1223 | 1.019 | 94 | 1213 | 1.011 | 37 | 9.2 | ||
Positive control (EMS) | 768 | 0.640 | 59 | 472 | 0.393 | 1120 | 710.4** | ||
DMBA = 7,12-Dimethylbenz[a]anthracene, 15 µg/mL; EMS = Ethyl methanesulfonate, 0.4 µL/mL; (P): precipitation observed at the end of treatment |
Table 3: Historical control data generated in the testing facility (updated in Oct 2017 using data of GLP studies)
Mutation frequency (Number of 6-TG resistant mutants per 10E6 clonable cells) |
|||
Untreated control | |||
5-hour, S9+ | 5-hour, S9- | 24-hour, S9- | |
mean | 18.3 | 20.7 | 19 |
standard deviation | 15.1 | 16.4 | 17.2 |
minimum | 5.1 | 5.5 | 3.3 |
maximum | 64.1 | 55.5 | 58 |
n | 27 | 13 | 14 |
DMSO control | |||
5-hour, S9+ | 5-hour, S9- | 24-hour, S9- | |
mean | 21.8 | 18.9 | 18.4 |
standard deviation | 15.9 | 11.6 | 14.4 |
minimum | 5.4 | 6.5 | 6.8 |
maximum | 57.3 | 47.4 | 48.5 |
n | 29 | 13 | 14 |
Distilled water / Water based vehicle control | |||
mean | 11.5 | 9.1 | 15.5 |
standard deviation | 3.8 | 3.4 | 5.6 |
minimum | 6.1 | 5.2 | 9.2 |
maximum | 15.8 | 11.6 | 20.1 |
n | 6 | 3 | 3 |
Positive controls | |||
DMBA | EMS | EMS | |
5-hour, S9+ | 5-hour, S9- | 24-hour, S9- | |
mean | 905.2 | 445.6 | 1176.6 |
standard deviation | 562.7 | 118.6 | 610.9 |
minimum | 141.2 | 239.6 | 363.1 |
maximum | 2119.4 | 636.6 | 2449.8 |
n | 27 | 13 | 14 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative in CHO cells with and without metabolic activation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.